Related references
Note: Only part of the references are listed.[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model
Ludwig Dubois et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
INHIBITION OF 4E-BP1 SENSITIZES U87 GLIOBLASTOMA XENOGRAFT TUMORS TO IRRADIATION BY DECREASING HYPOXIA TOLERANCE
Ludwig Dubois et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin
Sarah K. Harten et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
Jean-Philippe Cosse et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal
Henry Jay Forman et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Carbonic anhydrase IX: historical and future perspectives
Egbert Oosterwijk
BJU INTERNATIONAL (2008)
Development of small molecule carbonic anhydrase IX inhibitors
Claudiu T. Supuran
BJU INTERNATIONAL (2008)
Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia
Silvia Pastorekova et al.
BJU INTERNATIONAL (2008)
Cancer cell killing via ROS To increase or decrease, that is the question
Jie Wang et al.
CANCER BIOLOGY & THERAPY (2008)
Reactive species: A cell damaging rout assisting to chemical carcinogens
Mario E. Goetz et al.
CANCER LETTERS (2008)
Mechanisms of ROS modulated cell survival during carcinogenesis
J. S. Clerkin et al.
CANCER LETTERS (2008)
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy
Mayumi Ono
CANCER SCIENCE (2008)
Hypoxia in prostate cancer: A powerful shield against tumour destruction?
L. Marignol et al.
CANCER TREATMENT REVIEWS (2008)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: Results of a phase I study
Mark R. Albertella et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Marc Vooijs et al.
CURRENT MOLECULAR MEDICINE (2008)
Fluorescence- and spin-labeled carbonic anhydrase inhibitors
Alessandro Cecchi et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Cancer-associated carbonic anhydrases and their inhibition
S. Pastorekova et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
PET imaging with hypoxia tracers: a must in radiation therapy
Giovanni Lucignani
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours
S. Toffoli et al.
FEBS JOURNAL (2008)
Reactive oxygen species in phagocytic leukocytes
John M. Robinson
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia
Huafeng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths
Pawel Swietach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes
Mika Hilvo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Reductive heme-dependent activation of the N-oxide prodrug AQ4N by nitric oxide synthase
Clinton R. Nishida et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs
Anne Thiry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
Thomas G. Smith et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer
K. Hendricksen et al.
JOURNAL OF UROLOGY (2008)
Hypoxia-inducible factor-1 alpha stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion
Elisabeth L. Page et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity
Audrey Sermeus et al.
MOLECULAR CANCER (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Dissecting the Role of Multiple Reductases in Bioactivation and Cytotoxicity of the Antitumor Agent 2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1)
Chao Yan et al.
MOLECULAR PHARMACOLOGY (2008)
Expanding chemical biology of 2-oxoglutarate oxygenases
Christoph Loenarz et al.
NATURE CHEMICAL BIOLOGY (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Carbonic anhydrase IX: A new druggable target for the design of antitumor agents
Jean-Yves Winum et al.
MEDICINAL RESEARCH REVIEWS (2008)
iNOS as a therapeutic target for treatment of human tumors
Brian Fitzpatrick et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Transcriptional responses to intermittent hypoxia
Jayasri Nanduri et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2008)
The rnTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency
Michael G. Magagnin et al.
PROTEOMICS (2008)
NOX enzymes as novel targets for drug development
J. David Lambeth et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
Abnormal heart development and lung remodeling in mice lacking the hypoxia-inducible factor-related basic helix-loop-helix PAS protein NEPAS
Toshiharu Yamashita et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
M. Barathova et al.
BRITISH JOURNAL OF CANCER (2008)
Hypoxia signalling through mTOR and the unfolded protein response in cancer
Bradly G. Wouters et al.
NATURE REVIEWS CANCER (2008)
Loss of the SdhB, but not the SdhA subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis
Robert D. Guzy et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Hypoxia up-regulates hypoxia-inducible factor-1α transcription by involving phosphatidylinositol 3-kinase and nuclear factor κB in pulmonary artery smooth muscle cells
Rachida S. BelAiba et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Significance of HIF-1-active cells in angiogenesis and radioresistance
H. Harada et al.
ONCOGENE (2007)
Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor
Jens Koditz et al.
BLOOD (2007)
Reactive oxygen species and cellular oxygen sensing
Timothy P. Cash et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor α
Peppi Koivunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Bioreductive drugs: from concept to clinic
S. R. McKeown et al.
CLINICAL ONCOLOGY (2007)
Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI
Ken-Ichiro Matsumoto et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
J. David Lambeth
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V. Patterson et al.
CLINICAL CANCER RESEARCH (2007)
The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production
Eric L. Bell et al.
JOURNAL OF CELL BIOLOGY (2007)
Deficiency of manganese superoxide dismutase in hepatocytes disrupts zonated gene expression in mouse liver
Jacek Lenart et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Impact of supervised gene signatures of early hypoxia on patient survival
Renaud Seigneuric et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress
Michael G. Magagnin et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Phosphorylation of eIF2α is required for mRNA translation inhibition and survival during moderate hypoxia
Marianne Koritzinsky et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Hypoxia-imaging with 18F-misonidazole and PET:: Changes of kinetics during radiotherapy of head-and-neck cancer
Susanne Martina Eschmann et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Hypoxia, gene expression, and metastasis
Denise A. Chan et al.
CANCER AND METASTASIS REVIEWS (2007)
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
Huafeng Zhang et al.
CANCER CELL (2007)
Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
Elaine D. MacKenzie et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
Ryo Fukuda et al.
CELL (2007)
Reactive oxygen species activate the HIF-1α promoter via a functional NFκB site
Steve Bonello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate
Margret C. M. Vissers et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas:: hypoxia-induced transcription profile signifies metastatic potential
Princy Francis et al.
BMC GENOMICS (2007)
Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates -: Possible links between cell metabolism and stabilization of HIF
Peppi Koivunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
NOX5 variants are functionally active in endothelial cells
Rachida S. BelAiba et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
Kirsty S. Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro
Yi Pan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Hypoxia-induced genetic instability - a calculated mechanism underlying tumor progression
L. Eric Huang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
Mark W. Dewhirst
CANCER RESEARCH (2007)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (I-124-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R. Divgi et al.
LANCET ONCOLOGY (2007)
Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay
Dominic Ehrismann et al.
BIOCHEMICAL JOURNAL (2007)
The maximum uptake of F-18-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-lot and GLUT-1 in non-small cell lung cancer
Angela van Baardwijk et al.
EUROPEAN JOURNAL OF CANCER (2007)
Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: Possible role for thrombosis
Sherry A. Weppler et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Regulation of Cited2 expression provides a functional link between translational and transcriptional responses during hypoxia
Twan van den Beucken et al.
RADIOTHERAPY AND ONCOLOGY (2007)
A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations
Daniela Thorwarth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Mitochondria and reactive oxygen species in renal cancer
Eric Hervouet et al.
BIOCHIMIE (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Protein tyrosine phosphatases: from genes, to function, to disease
Nicholas K. Tonks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype
Linda Holmquist-Mengelbier et al.
CANCER CELL (2006)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L. Tatum et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer
Rajiv Puri et al.
JOURNAL OF UROLOGY (2006)
The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases
Peppi Koivunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer
Joseph G. Rajendran et al.
CLINICAL CANCER RESEARCH (2006)
Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway - A report of the tumour angiogenesis research group
Michael I. Koukourakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX
Giuseppina De Simone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia
Robert D. Guzy et al.
EXPERIMENTAL PHYSIOLOGY (2006)
Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels -: Evidence for an autoregulatory oxygen-sensing system
Daniel P. Stiehl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies
Michael G. Magagnin et al.
DRUG RESISTANCE UPDATES (2006)
Redox signaling in angiogenesis: Role of NADPH oxidase
Masuko Ushio-Fukai
CARDIOVASCULAR RESEARCH (2006)
HIF-I and tumour radiosensitivity
B. J. Moeller et al.
BRITISH JOURNAL OF CANCER (2006)
The connection between splicing and cancer
Anabella Srebrow et al.
JOURNAL OF CELL SCIENCE (2006)
Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein
Miguel A. Esteban et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX
Vincenzo Alterio et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells
Eileen Connolly et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Sensing and responding to hypoxia via HIF in model invertebrates
Thomas A. Gorr et al.
JOURNAL OF INSECT PHYSIOLOGY (2006)
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
Ian J. Clifton et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control
M Koritzinsky et al.
EMBO JOURNAL (2006)
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer:: a feasibility study -: art. no. 51
B Gagel et al.
BMC CANCER (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages:: Effect of natural res stance-associated macrophage protein 1
HJ Knowles et al.
CANCER RESEARCH (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers
JT Chi et al.
PLOS MEDICINE (2006)
Mechanisms of disease: angiogenesis in urologic malignancies
PJS Charlesworth et al.
NATURE CLINICAL PRACTICE UROLOGY (2006)
Hypoxia-induced energy stress regulates mRNA translation and cell growth
LP Liu et al.
MOLECULAR CELL (2006)
Endogenous markers of two separate, hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial
MI Koukourakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mitochondria: Oxygen sinks rather than sensors?
RH Wenger
MEDICAL HYPOTHESES (2006)
Advances in methods for assessing tumor hypoxia in vivo: Implications for treatment planning
Sonal Davda et al.
CANCER AND METASTASIS REVIEWS (2006)
NADPH oxidases in the gastrointestinal tract: A potential role of Nox1 in innate immune response and carcinogenesis
Kazuhito Rokutan et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Predicting a local recurrence after breast-conserving therapy by gene expression profiling
Dimitry S. A. Nuyten et al.
BREAST CANCER RESEARCH (2006)
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
MV Gustafsson et al.
DEVELOPMENTAL CELL (2005)
Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally-advanced cancers of the uterine cervix
A Mayer et al.
CLINICAL CANCER RESEARCH (2005)
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
MX Bi et al.
EMBO JOURNAL (2005)
Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function
NS Patel et al.
CANCER RESEARCH (2005)
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
J Overgaard et al.
LANCET ONCOLOGY (2005)
Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma
P Choi et al.
CANCER (2005)
Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II
V Menchise et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines
EGC Troost et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors
EO Pettersen et al.
CELL PROLIFERATION (2005)
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity
BJ Moeller et al.
CANCER CELL (2005)
The hypoxic proteome is influenced by gene-specific changes in mRNA translation
M Koritzinsky et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression
T Kietzmann et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors
A Cecchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation
KD Mansfield et al.
CELL METABOLISM (2005)
Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination
SJ Lunt et al.
CLINICAL CANCER RESEARCH (2005)
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
RD Guzy et al.
CELL METABOLISM (2005)
Understanding alternative splicing: Towards a cellular code
AJ Matlin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
KJ Williams et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Alterations of pre-mRNA splicing in cancer
Z Kalnina et al.
GENES CHROMOSOMES & CANCER (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Metabolic depression: a response of cancer cells to hypoxia?
M Guppy et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2005)
Gene profiling in squamous cell carcinoma of the head and neck
J Akervall
CANCER AND METASTASIS REVIEWS (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial
BG Haffty et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
CH Chung et al.
CANCER CELL (2004)
Hypoxia and glucose metabolism in malignant tumors:: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
JG Rajendran et al.
CLINICAL CANCER RESEARCH (2004)
Reactive oxygen species as mediators of signal transduction in ischemic preconditioning
H Otani
ANTIOXIDANTS & REDOX SIGNALING (2004)
Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases
P Koivunen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells
RS BelAiba et al.
BIOLOGICAL CHEMISTRY (2004)
Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX
S Pastorekova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: Reversing tumor radioresistance and effecting cure
RL Cowen et al.
CANCER RESEARCH (2004)
Targeting hypoxia tolerance in cancer
BG Wouters et al.
DRUG RESISTANCE UPDATES (2004)
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
F Abbate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Counteraction of pRb-dependent protection after extreme hypoxia by elevated ribonucleotide reductase
P Graff et al.
CELL PROLIFERATION (2004)
JunD reduces tumor angiogenesis by protecting cells from oxidative stress
D Gerald et al.
CELL (2004)
Activating transcription factor 4 is translationally regulated by hypoxic stress
JD Blais et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion
N Robertson et al.
CANCER RESEARCH (2004)
Hypoxia and defective apoptosis drive genomic instability and tumorigenesis
DA Nelson et al.
GENES & DEVELOPMENT (2004)
Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix
A Mayer et al.
CANCER RESEARCH (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Hypoxia-inducible factor lot expression as an intrinsic marker of hypoxia: Correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix
GJ Hutchison et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
New potentiomentric dissolved oxygen sensors in thick film technology
R Martínez-Máñez et al.
SENSORS AND ACTUATORS B-CHEMICAL (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Evaluation of hypoxia in an experimental rat tumour model by [18F]Fluoromisonidazole PET and immunohistochemistry
L Dubois et al.
BRITISH JOURNAL OF CANCER (2004)
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
E Svastová et al.
FEBS LETTERS (2004)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
V Garaj et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Determination and comparison of specific activity of the HIF-prolyl hydroxylases
JR Tuckerman et al.
FEBS LETTERS (2004)
Endogenous 2-oxoacids differentially regulate expression of oxygen sensors
CL Dalgard et al.
BIOCHEMICAL JOURNAL (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2003)
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
M Hirsilä et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma
A Chrastina et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
CPS Potter et al.
BRITISH JOURNAL OF CANCER (2003)
Regulation of angiogenesis by hypoxia: role of the HIF system
CW Pugh et al.
NATURE MEDICINE (2003)
The hypoxia-inducible factor-1α is a negative factor for tumor therapy
A Unruh et al.
ONCOGENE (2003)
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas
M Nordsmark et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 uhiquitin ligase complex
MA Maynard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Pre-mRNA splicing and human disease
NA Faustino et al.
GENES & DEVELOPMENT (2003)
Molecular (functional) imaging for radiotherapy applications: An RTOG symposium
JD Chapman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer
DEB Swinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin
E Svastova et al.
EXPERIMENTAL CELL RESEARCH (2003)
Hypoxia-inducible factor 1 alpha is essential for cell cycle arrest during hypoxia
N Goda et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Combining bioreductive drugs and radiation for the treatment of solid tumors
IJ Stratford et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Functional cellular assays with multiparametric silicon sensor chips
M Brischwein et al.
LAB ON A CHIP (2003)
Microenvironmental and cellular consequences of altered blood flow in tumours
N Raghunand et al.
BRITISH JOURNAL OF RADIOLOGY (2003)
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice
MV Papadopoulou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
HLK Janssen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9
PM Loadman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2α
C Koumenis et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α
DA Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phosphorous metabolites and steady-state energetics of transformed fibroblasts during three-dimensional growth
LA Kunz-Schughart et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus
Y Makino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tumor microenvironment and the response to anticancer therapy
JM Brown
CANCER BIOLOGY & THERAPY (2002)
Expression of hypoxia-inducible factor-1α and -2α in hypoxic and ischemic rat kidneys
C Rosenberger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours
AV Patterson et al.
GENE THERAPY (2002)
HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron
SJ Mandriota et al.
CANCER CELL (2002)
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements -: Infuence of tumour volume and carbogen breathing
L Bentzen et al.
ACTA ONCOLOGICA (2002)
Dephosphorylation of cell cycle-regulated proteins correlates with anoxia-induced suspended animation in Caenorhabditis elegans
PA Padilla et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
Hypoxia as a target for combined modality treatments
BG Wouters et al.
EUROPEAN JOURNAL OF CANCER (2002)
Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells
S Masunaga et al.
EUROPEAN JOURNAL OF CANCER (2002)
Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression
Y Makino et al.
NATURE (2001)
Structure and function of the radical enzyme ribonucleotide reductase
H Eklund et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2001)
The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N
R Gallagher et al.
BRITISH JOURNAL OF CANCER (2001)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2001)
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice
MV Papadopoulou et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells role of the p22phox-containing NADPH oxidase
A Görlach et al.
CIRCULATION RESEARCH (2001)
Oxygen deprivation causes suspended animation in the zebrafish embryo
PA Padilla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mitochondrial DNA in human malignancy
JS Penta et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2001)
Hypoxia in human soft tissue sarcomas:: Adverse impact on survival and no association with p53 mutations
M Nordsmark et al.
BRITISH JOURNAL OF CANCER (2001)
Biological consequences of tumor hypoxia
M Höckel et al.
SEMINARS IN ONCOLOGY (2001)
Hypoxia inhibits G1/S transition through regulation of p27 expression
LB Gardner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Semiquantitative immunohistochemical analysis for hypoxia in human tumors
JA Raleigh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
p21Cip1 and p27Kip1 regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest
SL Green et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Efficient translation of mouse hypoxia-inducible factor-1α under normoxic and hypoxic conditions
A Görlach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2000)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
The relative importance of NADPH:: Cytochrome c (P450) reductase for determining the sensitivity of human tumour cells to the indolequinone EO9 and related analogues lacking functionality at the C-2 and C-3 positions
MP Saunders et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Metabolic imaging in multicellular spheroids of oncogene-transfected fibroblasts
S Walenta et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
Identification of alternative spliced variants of human hypoxia-inducible factor-1α
E Gothié et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice
PM Loadman et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine
OP Friery et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
